(S)-alpha-amino-cyclopropanepropanamide → 5-Chloro-4-cyclopropylmethoxy-pyridine-2-carboxylic acid ((S)-1-carbamoyl-2-cyclopropyl-ethyl)-amide

HRID 1480041

Reaktionsgleichung

Reaktionsgleichung von HRID 1480041
[Cl:1][C:2]1[C:3]([O:11][CH2:12][CH:13]2[CH2:15][CH2:14]2)=[CH:4][C:5]([C:8]([OH:10])=O)=[N:6][CH:7]=1.[NH2:16][C@@H:17]([CH2:21][CH:22]1[CH2:24][CH2:23]1)[C:18]([NH2:20])=[O:19]>>[C:18]([C@@H:17]([NH:16][C:8]([C:5]1[CH:4]=[C:3]([O:11][CH2:12][CH:13]2[CH2:15][CH2:14]2)[C:2]([Cl:1])=[CH:7][N:6]=1)=[O:10])[CH2:21][CH:22]1[CH2:24][CH2:23]1)(=[O:19])[NH2:20]

Komponenten

3

Versuchsvorschrift

The title compound was synthesized in analogy to Example 1, using 5-chloro-4-cyclopropylmethoxy-pyridine-2-carboxylic acid and (S)-α-amino-cyclopropanepropanamide (CAN 156077-93-9) as starting materials and isolated (18 mg, 53%) as white solid; MS (ESI, m/z): 338.3 (MH+).

Aufarbeitung

  1. customisolated (18 mg, 53%) as white solid

Quellen und Nachweise

ORD-Eintrag
ord-a68796482c844af2a52e2b4a12bc455c
Quelldatensatz
uspto-grants-2016_08
Patentnummer
US09409866B2

Verknüpfte Notizen

Wird geladen…